tiprankstipranks
Holding NANC?
Track your performance easily

NANC ETF Forecast & Price Targets

See the Price Targets and Ratings of:

NANC Analyst Ratings

Moderate Buy
735ConsensusRatings
542 Buy
175 Hold
18 Sell
Based on the consensus analyst ratings on 735 stocks held in NANC.
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

NANC 12 Months Forecast

Average Price Target

$37.87
Based on 735 Wall Street analysts offering 12 month price targets to NANC holdings in the last 3 months. The average price target is $37.87 with a high forecast of $45.59 and a low forecast of $30.69. The average price target represents a 14.69% change from the last price of $33.02.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"plus_tr_sans","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"24":"$24","35":"$35","46":"$46","29.5":"$29.5","40.5":"$40.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":45.586,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n  <span style=\"color:#199ca5\">$45.59</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":37.872,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n  <span style=\"color:#828080\">$37.87</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":30.692,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n  <span style=\"color:#912767\">$30.69</span>\n  </div></div>","useHTML":true}}],"tickPositions":[24,29.5,35,40.5,46],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2023","6":"Oct<br/>2023","9":"Jan<br/>2024","12":"Apr<br/>2024","25":"Apr<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n              \n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,34.46,35.31584615384615,36.17169230769231,37.02753846153846,37.883384615384614,38.73923076923077,39.595076923076924,40.450923076923075,41.306769230769234,42.162615384615385,43.01846153846154,43.874307692307696,44.73015384615385,{"y":45.586,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,34.46,34.72246153846154,34.984923076923074,35.24738461538462,35.509846153846155,35.77230769230769,36.03476923076923,36.29723076923077,36.55969230769231,36.822153846153846,37.08461538461538,37.347076923076926,37.60953846153846,{"y":37.872,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,34.46,34.170153846153845,33.880307692307696,33.59046153846154,33.300615384615384,33.010769230769235,32.72092307692308,32.43107692307692,32.141230769230766,31.851384615384617,31.56153846153846,31.27169230769231,30.981846153846153,{"y":30.692,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":25.02,"date":1680480000000,"info":"<div>Price: <b>$25<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":25.12,"date":1682899200000,"info":"<div>Price: <b>$25<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":26.22,"date":1685577600000,"info":"<div>Price: <b>$26<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":27.6,"date":1688342400000,"info":"<div>Price: <b>$28<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":28.54,"date":1690848000000,"info":"<div>Price: <b>$29<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":28.23,"date":1693526400000,"info":"<div>Price: <b>$28<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":26.79,"date":1696204800000,"info":"<div>Price: <b>$27<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":26.56,"date":1698796800000,"info":"<div>Price: <b>$27<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":29.31,"date":1701388800000,"info":"<div>Price: <b>$29<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":30.17,"date":1704153600000,"info":"<div>Price: <b>$30<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":31.69,"date":1706745600000,"info":"<div>Price: <b>$32<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":33.47,"date":1709251200000,"info":"<div>Price: <b>$33<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":34.46,"date":1711929600000,"info":"<div>Price: <b>$34<b/></div>","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$45.59Average Price Target$37.87Lowest Price Target$30.69
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

NANC Stocks With Highest Upside Potential

Name
Price & Change
Analyst Consensus
Analyst Price Target
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Revance Therapeutics
7 Buy
3 Hold
0 Sell
Moderate Buy
$15.80
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Emcore Corporation
3 Buy
0 Hold
0 Sell
Strong Buy
$11.83
xxxxxxxxxxxxxxxxxxxxxxxxxxx
WW International Inc
4 Buy
3 Hold
1 Sell
Moderate Buy
$5.75
xxxxxxxxxxxxxxxxxxxxxxxxxxx
BioCryst Pharmaceuticals
7 Buy
1 Hold
0 Sell
Strong Buy
$15.25
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Clean Energy Fuels
7 Buy
1 Hold
0 Sell
Strong Buy
$7.00

NANC Stocks With Highest Downside Potential

No stocks with downside potential were found for this ETF
Please check back later or explore other ETFs for potential investment opportunities.

NANC ETF FAQ

What is NANC’s average 12-month price target, according to analysts?
Based on analyst ratings, NANC’s 12-month average price target is $37.87.
    What is NANC’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for NANC, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is NANC a Buy, Sell or Hold?
        NANC has a conensus rating of Moderate Buy which is based on 542 buy ratings, 175 hold ratings and 18 sell ratings.
          What is NANC’s price target?
          The average price target for NANC is $37.87. This is based on 735 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst price target is $45.59 ,the lowest forecast is $30.69. The average price target represents N/A Increase from the current price of N/A.
            What do analysts say about NANC?
            NANC’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 735 Wall Streets Analysts.
              How can I buy shares of NANC?
              Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis